Angela Webster

Last updated
Professor
Angela Webster
FAHMS
Personal details
NationalityAustralian
Occupation Epidemiologist, nephrologist

Angela Webster is a clinical epidemiologist at the Sydney School of Public Health, University of Sydney, nephrologist and transplant physician at Westmead Hospital and director of Evidence Integration at the NHMRC Clinical Trials Centre, University of Sydney.

Contents

Biography

Webster is a clinical academic with a focus on transplant medicine, kidney disease and epidemiology.

Webster's research themes include multimorbidity and the interaction of chronic diseases, specifically kidney disease, cancer, cardiovascular disease, diabetes, infection, and mental illness, addressed through evidence integration. Her researched is focused on improving clinical outcomes and using data to improve clinical decision making, by communicating and evaluating risk. She has a particular interest in health inequalities and mitigating factors that create disadvantage in health and healthcare settings.

Select publications

YearTitleJournalRef
2017Chronic Kidney DiseaseThe Lancet [1]
2021Sex differences in mortality among binational cohort of people with chronic kidney disease: population based data linkage studyBMJ [2]
2016Cognition in chronic kidney disease: a systematic review and meta-analysisBiomed Central Medicine. [3]
2015Readability of Written Materials for CKD Patients: A Systematic Review.American Journal of Kidney Diseases [4]
2021Supporting patients to be involved in decisions about their health and care: Development of a best practice health literacy App for Australian adults living with Chronic Kidney Disease.Health Promotion Journal of Australia [5]
2019Residual risk of infection with blood-borne viruses in potential organ donors at increased risk of infection: systematic review and meta-analysis.Medical Journal of Australia [6]
2014Survival after cutaneous melanoma in kidney transplant recipients: a population-based matched cohort studyAmerican Journal of Transplantation [7]
2021The landscape of COVID-19 trials in AustraliaMedical Journal of Australia. [8]
2022Searching clinical trials registers: guide for systematic reviewers.BMJ [9]
2013Interventions for smoking cessation and reduction in individuals with schizophreniaCochrane Database of Systematic Reviews [10]

Awards

YearAwardOrganisationRef
2023Elected as Fellow of the Australian Academy of Health and Medical SciencesAustralian Academy of Health and Medical Sciences [11]
2020TJ Neale Award for Outstanding Contribution to Nephrological ScienceAustralian and New Zealand Society of Nephrology
2019Josette Eris Memorial Award for emerging female leadersTransplantation Society of Australia and New Zealand
2015Ian McKenzie Prize for outstanding contribution in transplantationTransplantation Society of Australia and New Zealand

References

  1. ↑ Webster, Angela C; Nagler, Evi V; Morton, Rachael L; Masson, Philip (March 2017). "Chronic Kidney Disease" . The Lancet. 389 (10075): 1238–1252. doi:10.1016/S0140-6736(16)32064-5. PMID   27887750. S2CID   4925820.
  2. ↑ De La Mata, Nicole L; Rosales, Brenda; MacLeod, Grace; Kelly, Patrick J; Masson, Philip; Morton, Rachael L; Wyburn, Kate; Webster, Angela C (2021-11-16). "Sex differences in mortality among binational cohort of people with chronic kidney disease: population based data linkage study". BMJ. 375: e068247. doi: 10.1136/BMJ-2021-068247 . ISSN   1756-1833. PMC   8593820 . PMID   34785509.
  3. ↑ Berger, Israel; Wu, Sunny; Masson, Philip; Kelly, Patrick J.; Duthie, Fiona A.; Whiteley, William; Parker, Daniel; Gillespie, David; Webster, Angela C. (December 2016). "Cognition in chronic kidney disease: a systematic review and meta-analysis". BMC Medicine. 14 (1): 206. doi: 10.1186/s12916-016-0745-9 . ISSN   1741-7015. PMC   5155375 . PMID   27964726.
  4. ↑ Morony, Suzanne; Flynn, Michaela; McCaffery, Kirsten J.; Jansen, Jesse; Webster, Angela C. (June 2015). "Readability of Written Materials for CKD Patients: A Systematic Review" . American Journal of Kidney Diseases. 65 (6): 842–850. doi:10.1053/j.ajkd.2014.11.025. hdl: 2123/22350 . PMID   25661679.
  5. ↑ Muscat, Danielle Marie; Lambert, Kelly; Shepherd, Heather; McCaffery, Kirsten J.; Zwi, Stephanie; Liu, Na; Sud, Kamal; Saunders, John; O’Lone, Emma; Kim, Jinman; Robbins, Aphra; Webster, Angela C. (February 2021). Smith, James (ed.). "Supporting patients to be involved in decisions about their health and care: Development of a best practice health literacy App for Australian adults living with Chronic Kidney Disease". Health Promotion Journal of Australia. 32 (S1): 115–127. doi: 10.1002/hpja.416 . ISSN   1036-1073. PMID   32888215.
  6. ↑ Waller, Karen MJ; De La Mata, Nicole L; Kelly, Patrick J; Ramachandran, Vidiya; Rawlinson, William D; Wyburn, Kate R; Webster, Angela C (November 2019). "Residual risk of infection with blood-borne viruses in potential organ donors at increased risk of infection: systematic review and meta-analysis" . Medical Journal of Australia. 211 (9): 414–420. doi:10.5694/mja2.50315. ISSN   0025-729X. PMID   31489635. S2CID   201846138.
  7. ↑ Vajdic, C.M.; Chong, A.H.; Kelly, P.J.; Meagher, N.S.; Van Leeuwen, M.T.; Grulich, A.E.; Webster, A.C. (June 2014). "Survival After Cutaneous Melanoma in Kidney Transplant Recipients: A Population-Based Matched Cohort Study" . American Journal of Transplantation. 14 (6): 1368–1375. doi:10.1111/ajt.12716. hdl: 2123/22309 . PMID   24730453. S2CID   7791631.
  8. ↑ Seidler, Anna Lene; Aberoumand, Mason; Williams, Jonathan G; Tan, Aidan; Hunter, Kylie E; Webster, Angela (2021-07-19). "The landscape of COVID-19 trials in Australia". Medical Journal of Australia. 215 (2): 58–61.e1. doi:10.5694/mja2.51148. ISSN   0025-729X. PMC   8447014 . PMID   34275134.
  9. ↑ Hunter, Kylie E; Webster, Angela C; Page, Matthew J; Willson, Melina; McDonald, Steve; Berber, Slavica; Skeers, Peta; Tan-Koay, Ava G; Parkhill, Anne; Seidler, Anna Lene (2022-04-26). "Searching clinical trials registers: guide for systematic reviewers". BMJ. 377: e068791. doi: 10.1136/bmj-2021-068791 . ISSN   1756-1833. PMID   35473822.
  10. ↑ Tsoi, Daniel T; Porwal, Mamta; Webster, Angela C (2013-02-28). Cochrane Tobacco Addiction Group (ed.). "Interventions for smoking cessation and reduction in individuals with schizophrenia". Cochrane Database of Systematic Reviews. 2013 (2): CD007253. doi:10.1002/14651858.CD007253.pub3. PMC   6486303 . PMID   23450574.
  11. ↑ Tamowicz, Celeste (2023-10-12). "Professor Angela Webster". Australian Academy of Health and Medical Sciences. Retrieved 2023-11-24.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.